Rich Christopher is a pharmaceutical and medical device executive who currently serves as Chief Executive Officer of Lexaria Bioscience Corp. They have led Lexaria Bioscience (Nasdaq: LEXX), a global innovator in drug delivery platforms, since 2024, with a focus on DehydraTECH and the GLP-1 and hypertension markets. They previously served as Chief Financial Officer at InVivo Therapeutics (2019–2024) and as Chief Financial & Operating Officer at Caliber Imaging & Diagnostics (2014–2016). Earlier in their career, they were VP Finance & CFO at DUSA Pharmaceuticals (2000–2013) and Executive Vice President & CFO at iCAD (2016–2019). They earned a BS in Finance from Bentley University and an MSA in Accounting from Suffolk University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices